151 related items for PubMed ID: 15807878
1. Final adult height and body mass index after cure of paediatric Cushing's disease.
Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO.
Clin Endocrinol (Oxf); 2005 Apr; 62(4):466-72. PubMed ID: 15807878
[Abstract] [Full Text] [Related]
2. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
Savage MO, Lienhardt A, Lebrethon MC, Johnston LB, Huebner A, Grossman AB, Afshar F, Plowman PN, Besser GM.
Horm Res; 2001 Apr; 55 Suppl 1():24-30. PubMed ID: 11408758
[Abstract] [Full Text] [Related]
3. Growth in disorders of adrenal hyperfunction.
Savage MO, Scommegna S, Carroll PV, Ho JT, Monson JP, Besser GM, Grossman AB.
Horm Res; 2002 Apr; 58 Suppl 1():39-43. PubMed ID: 12373013
[Abstract] [Full Text] [Related]
4. Linear growth and final height after treatment for Cushing's disease in childhood.
Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO.
J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
[Abstract] [Full Text] [Related]
5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF, McNeill E, Young D, Donaldson MD.
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[Abstract] [Full Text] [Related]
6. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Nov; 12(1):31-4. PubMed ID: 16704859
[Abstract] [Full Text] [Related]
7. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO.
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[Abstract] [Full Text] [Related]
8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B.
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[Abstract] [Full Text] [Related]
9. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO.
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[Abstract] [Full Text] [Related]
10. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A, Kabra M, Gupta AK, Menon PS.
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[Abstract] [Full Text] [Related]
11. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
Schmidt H, Bechtold S, Schwarz HP.
Eur J Med Res; 2000 Jul 19; 5(7):307-10. PubMed ID: 10903191
[Abstract] [Full Text] [Related]
12. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
J Pediatr Gastroenterol Nutr; 2007 Oct 19; 45(4):433-7. PubMed ID: 18030209
[Abstract] [Full Text] [Related]
13. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
Mouat F, Hofman PL, Jefferies C, Gunn AJ, Cutfield WS.
Clin Endocrinol (Oxf); 2009 May 19; 70(5):751-6. PubMed ID: 19178517
[Abstract] [Full Text] [Related]
14. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
Horm Res; 2009 May 19; 71(3):167-72. PubMed ID: 19188742
[Abstract] [Full Text] [Related]
15. Growth and growth hormone secretion in paediatric Cushing's disease.
Savage MO, Storr HL, Grossman AB, Krassas GE.
Hormones (Athens); 2003 May 19; 2(2):93-7. PubMed ID: 17003007
[Abstract] [Full Text] [Related]
16. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G, Iliev DI, Mullis PE, Ranke MB.
Growth Horm IGF Res; 2007 Jun 19; 17(3):242-8. PubMed ID: 17360215
[Abstract] [Full Text] [Related]
17. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
Horm Res; 2007 Jun 19; 68(5):236-43. PubMed ID: 17396034
[Abstract] [Full Text] [Related]
18. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
Binder G, Trebar B, Baur F, Schweizer R, Ranke MB.
Clin Endocrinol (Oxf); 2008 Apr 19; 68(4):567-72. PubMed ID: 17973940
[Abstract] [Full Text] [Related]
19. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
Clin Endocrinol (Oxf); 2007 Oct 19; 67(4):485-92. PubMed ID: 17561977
[Abstract] [Full Text] [Related]
20. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
Trollmann R, Bakker B, Lundberg M, Doerr HG.
Pediatr Rehabil; 2006 Oct 19; 9(2):144-8. PubMed ID: 16449073
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
